Purchases and Sales Made in Q3 2024 in Chemomab Therapeutics Ltd. (CMMB)
This table provides information about the institutional ownership of Chemomab Therapeutics Ltd. (CMMB) during Q3 2024. The information is specifically focused on institutions that hold shares of Chemomab Therapeutics Ltd..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2024
Q3 2024
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
BUY
|
- |
1.21MNew |
$1.13M - $2.99M
|
1.21M
$2.21M
|
|
|
Oct 15, 2024
Q3 2024
|
Yelin Lapidot Holdings Management Ltd.
Tel Aviv, L3 |
BUY
|
- |
810KNew |
$753K - $1.99M
|
810K
$1.47M
|
|
|
Nov 14, 2024
Q3 2024
|
Morgan Stanley
New York, NY |
BUY
|
- |
395K+ 5487.11% |
$367K - $972K
|
402K
$732K
|
|
|
Nov 14, 2024
Q3 2024
|
Two Sigma Securities, LLC
New York, NY |
BUY
|
- |
39.9KNew |
$37.1K - $98.2K
|
39.9K
$72.7K
|
|
|
Nov 12, 2024
Q3 2024
|
Hrt Financial LP
New York, NY |
BUY
|
- |
13.6KNew |
$12.6K - $33.4K
|
13.6K
$24.7K
|
|
|
Nov 14, 2024
Q3 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
10.6KNew |
$9.83K - $26K
|
10.6K
$19.2K
|
|
|
Nov 12, 2024
Q3 2024
|
Rhumbline Advisers
Boston, MA |
BUY
|
- |
7.7K+ 38.72% |
$7.16K - $18.9K
|
27.6K
$50.2K
|
|
|
Nov 14, 2024
Q3 2024
|
Ubs Group Ag
|
BUY
|
- |
2.29KNew |
$2.13K - $5.63K
|
2.29K
$4.16K
|
|
|
Dec 26, 2024
Q3 2024
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
1.1K+ 110000.0% |
$1.02K - $2.71K
|
1.1K
$2K
|
|
|
Nov 08, 2024
Q3 2024
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
1.1K+ 110000.0% |
$1.02K - $2.71K
|
1.1K
$2K
|
|
|
Nov 14, 2024
Q3 2024
|
Xtx Topco LTD
London, X0 |
BUY
|
- |
157+ 1.04% |
$146 - $386
|
15.2K
$27.7K
|
|
|
Oct 10, 2024
Q3 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 14, 2024
Q3 2024
|
Orbimed Advisors LLC
San Diego, CA |
SELL
|
- |
-500K- 22.31% |
$465K - $1.23M
|
1.74M
$3.17M
|